Are you planning to present a paper at the Abralin's international conference, InterAb, which is scheduled to take place in 2023? CadLin is the official publication of papers presented at InterAb. If you are going to participate in InterAb and want to see your paper published in CadLin, you should be aware of some very important guidelines.
1. The policy of the CadLin is to publish papers where authors indicate whether or not the conducted research was preregistered with or without an analysis plan in an independent, institutional registry (e.g., ClinicalTrials.gov, AEA RCT Registry, OSF, EGAP Registry, RIDIE).
2. Research involving human subjects, human material, or human data must have been conducted in accordance with the principles of respect for persons, beneficence, and justice as outlined by the Belmont Report. Where applicable, the studies must have been approved by an appropriate ethics committee, and the authors should include a statement within the article text detailing this approval, including the name of the ethics committee and reference number of the approval.
3. The policy of the CadLin is to publish papers only if the data, methods used in the analysis, and materials used to conduct the research are clearly and precisely documented and are maximally available at a trusted digital repository (e.g. Zenodo, figshare and OSF) to any researcher for purposes of reproducing the results or replicating the procedure. All materials supporting the claims made by the author must be made available to the journal prior to publication.
4. Authors are required to review the standards available for many research applications from the Equator Network and use those that are relevant for the reported research applications. At manuscript submission, authors must confirm that they reviewed the standards, report whether any standards were relevant for the research application, and confirm that they followed those standards in the manuscript.
We advise authors to read CadLin's Guidelines in detail before even starting their study. CadLn is committed to Research Transparency and Open Science.
